Millennium Healthcare — Investor Presentation (April 2014)
21 slides from Millennium Healthcare's investor presentation, Apr 8, 2014
Slide 1: Providers of Exclusive Medical Devices & Services to Primary Care Practices
OTCQB: MHCC Providers of Exclusive Medical Devices & Services to Primary Care Practices INVESTOR PRESENTATION April 2014
Slide 2: Forward Looking Statements
2 Forward Looking Statements Included in this presentation are “forward - looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995 , as well as historical information . Such forward - looking statements involve known and unknown risks, uncertainties and other fa
Slide 3: Financial & Public Market Snapshot
3 Financial & Public Market Snapshot OTCQB: MHCC Share Price (04/07/14) $1.18 Market Cap (04/07/14) ~$80 M 3 mo. Avg. Daily Volume 80,208 52 Week Range $0.20 - $1.50 Mgmt. Ownership 42% Common Shares Outstanding 67.3 M Float 4.9 M 9M 2013 Revenue $1.5 M Gross Margins 100% 9M 2013 Net Income ($5.7) M
Slide 4: Why Invest in Millennium Healthcare
4 Why Invest in Millennium Healthcare • Affordable Care Act focuses on prevention and early detection of high cost illnesses to avert specialists and patients from invasive, costly procedures and long - term care. • Preventative care devices and medicines are one of the fastest growing healthcare se
Slide 5: Corporate History
5 Corporate History • Founded in 2008 by a group of medical/surgical doctors, entrepreneurs and financial and legal professionals. • Dedicated to dramatically improving and enhancing patient care and physician efficiency by providing practice development, support and administration services, includi
Slide 6: Executive Management
6 Executive Management Dominick Sartorio – Chief Executive Officer & Chairman - previously served as Director of New Business for Legacy Management Consulting Group , creating and implementing initiatives for client companies worth up to $ 550 million in annual sales . Mr . Sartorio was placed as ac
Slide 7: Market Drivers in U.S. Healthcare
7 Market Drivers in U.S. Healthcare Care Management and Devices Lead • Sheer demand for back - end office staff growing double digit • The number of medical codes under ICD - 10 will grow to over 140,000 from a current 20,000 1 • Use of medical devices is growing exponentially with new products in t
Slide 8: Millennium's Market Position in Healthcare Practice Management & Medical Devices
8 Millennium's Market Position in Healthcare Practice Management & Medical Devices Millennium Healthcare is support s ervices and distribution company leveraging practice management to drive revenues in high - growth, early - detection for cancer and cardiovascular disease Practice Management and Va
Slide 9: Millennium Practice Management Core Business Segment
9 Millennium Practice Management Core Business Segment • Full suite of back - office management services for medical practices. • Services are ICD - 10 compliant and include all aspects of medical billing and collections along with medical diagnosis and procedure coding and training for ICD - 10, el
Slide 10: Practice Management Business Unique Value for a Fast-Growing Market
10 Practice Management Business Unique Value for a Fast - Growing Market • A - la - cart pricing for various services • Currently servicing approximately 200 clients including primary care physicians in NY/NJ region • Client base growing at approximately 50% per year • Key group for business develop
Slide 11: Affordable Care Act Market Opportunity for Preventatives and Early Stage Detection
11 Affordable Care Act Market Opportunity for Preventatives and Early Stage Detection Affordable Care Act • Cost of all preventative testing covered 100% by Medicare and private carriers as of January 2014 • Immediate anticipated impact = significant increase in demand for medical tests • Goal is to
Slide 12: Medical Devices
12 Medical Devices Detection and Prevention Devices’ In - Room Advantages • Millennium's products are cost effective, FDA approved and reimbursable by Medicare and Insurance providers. • Products focus on preventative and diagnostic testing , designed to be used in the routine patient assessment pha
Slide 13: Medical Devices Products
13 Oral CDx Brush Test for Oral Cancer DermCDx ™ Skin Cancer Test VasoScan ANS Test Exclusive U.S. Distribution Medical Devices Products Leading FDA - Approved Screening Products Current Products • Capitalizing on more than more than 200 existing client relationships within practice management busin
Slide 14: Oral CDx BrushTest
14 Oral Cdx BrushTest ™ • The Oral Cdx BrushTest ™ is a clinically - proven , non - invasive test, which can help detect oral cancer by allowing quick, easy, painless, accurate and routine detection of oral dysplasia , including the HPV virus. • Designed to be used in the routine patient assessment
Slide 15: Patented and Proprietary Components
15 Patented and Proprietary Components A patented brush biopsy method of sampling oral spots that can be easily performed by any physician , nurse practitioner, physician’ s assistant, clinician or dentist. The resultant tissue specimen is then sent to the CDx laboratory for testing and results. A p
Slide 16: DermCDx Skin Cancer Test
16 DermCDx ™ Skin Cancer Test • DermCDx is a minimally invasive test that combines a patented brush biopsy sampling instrument with computer - assisted three dimensional laboratory analysis. • Brush biopsy test kit used to confirm basal cell carcinoma (BCC) resulting in expedited referral to a derma
Slide 17: VasoScan
17 VasoScan ™ • VasoScan is designed to analyze the ANS ( Autonomic Nervous System ) function, Stress and Peripheral Blood Circulation. • Provides objective data to help assess disorders such as Depression, Anxiety, Sleep disorder, Poor concentration, Mental/physical stress degree, chronic fatigue a
Slide 18: VasoScan Market Penetration
18 VasoScan ™ Market Penetration • SAAS (service as a software) cloud - based, HIPPA compliant • Single hardware unit, pay - per - test • Contracted for minimum 200 units in calendar year 2014 • Average PCP in network sees 50 to 150 patients per day
Slide 19: Current Financial Overview
19 Current Financial Overview Unaudited NINE MONTHS ENDED SEPTEMBER 30, 2013 NINE MONTHS ENDED SEPTEMBER 30, 2012 Revenue 1,483,107 1,158,511 Gross Profit 1,483,107 1,158,511 Total operating expenses 7,224,222 2,548,226 Net Income (Loss) (5,740,481) (5,291,125) Net Earnings (Loss) Per Share – Basic
Slide 20: Investment Summary
20 Investment Summary • Rapidly - growing preventative care device market driven by Affordable Care Act legislation • E xclusive contracts for innovative, FDA - approved and reimbursable devices (3 devices currently in pipeline, 1 pending) • Competitive advantages through established physician netwo
Slide 21: Contact
21 Contact Millennium Healthcare, Inc. 400 Garden City Plaza Suite – 440 Garden City, NY 11530 www.millenniumhcs.com John Mattio Investor Relations Telephone: 516 - 628 - 5500 investor@millenniumhcs.com
Millennium Healthcare — Investor Presentation (April 2014) on 6ix